NEW YORK — Vinay Prasad, the Food and Drug Administration’s top vaccines regulator, attributed the mounting criticism of his leadership to what he described as “misleading media narratives.” His comments, made during a closed-door investor conference in New York, come in the wake of a public warning issued by 12 former FDA commissioners regarding his proposed changes to vaccine policy, which they argue could have severe implications for public health.
As the director of the Center for Biologics Evaluation and Research and the agency’s chief medical and scientific officer, Prasad defended his plan to mandate longer and larger studies for vaccine updates. He emphasized that this initiative is aimed at modernizing FDA policy rather than undermining existing protocols. Prasad’s remarks reflect a critical moment for the FDA, as the agency navigates the complexities of vaccine regulation amidst heightened scrutiny and a need for public trust.
Use the database as your supply chain compass →
